Richard Shell
Pediatric Pulmonology Columbus, OH Medical Doctor
NPI 1497741110 CMS profile 719197
555 S 18Th St, Columbus, OH 43205
General payments
$44,030
Research payments
$1,109
Ownership & investment interest
$0
Through program year 2025, Richard Shell of Columbus, OH is reported in the CMS Open Payments database as having received $44,030 across 100 general payments and $1,109 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 96th percentile of Pediatric Pulmonology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
8 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $3,226 | 7 | |
| 2024 | Research | $625 | 1 | |
| 2023 | General | $7,366 | 15 | |
| 2022 | General | $12,718 | 20 | |
| 2021 | General | $2,502 | 3 | |
| 2021 | Research | $484 | 1 | |
| 2020 | General | $9,553 | 24 | |
| 2019 | General | $8,665 | 31 |
Beside peers
- Richard Shell
- Pediatric Pulmonology median
- Middle half of Pediatric Pulmonology
- National median
In program year 2025, general payments to Richard Shell were reported at $3,226. Among 622 Pediatric Pulmonology profiles paid that year, the median was $139 and the middle half received between $60 and $405.
Show as a table
| Year | Richard Shell | Pediatric Pulmonology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $8,665 | $151 | $59–$495 | $163 |
| 2020 | $9,553 | $107 | $34–$339 | $114 |
| 2021 | $2,502 | $125 | $40–$511 | $132 |
| 2022 | $12,718 | $133 | $49–$428 | $149 |
| 2023 | $7,366 | $138 | $44–$494 | $160 |
| 2024 | $0 | $132 | $46–$398 | $164 |
| 2025 | $3,226 | $139 | $60–$405 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
25
Drug cost
$6,027
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Fluticasone Propionate Hfa Fluticasone Propionate | Brand | 25 | $6,027 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,233 Part D prescribers listed as Pulmonary Disease; they describe a distribution and say nothing about conduct.
Records
102 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Pulmonology in Ohio
Theresa Guilbert
Pediatric Pulmonology · Cincinnati, OH
Michael Konstan
Pediatric Pulmonology · Cleveland, OH
Christopher Towe
Pediatric Pulmonology · Cincinnati, OH
Erik Hysinger
Pediatric Pulmonology · Cincinnati, OH
Erica Roesch
Pediatric Pulmonology · Cleveland, OH
Christopher Siracusa
Pediatric Pulmonology · Cincinnati, OH
Related records
Pediatric Pulmonology in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Pulmonology
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.